Subarachnoid Hemorrhage in Patient with End-Stage Renal Disease Secondary to Thrombocytopenia
Main Article Content
Abstract
This is a case report of a 60-year-old patient with renal disease of 21 years of evolu5on without renal replacement therapy, as well as systemic arterial hypertension with poor adherence to treatment, began his condi5on with indifference to the environment, drowsiness, admiDed to the emergency room where, thrombocytopenia and in cabinet studies take computed tomography of the skull with report of subarachnoid hemorrhage. The patient presents with thrombocytopenia due to consump5on secondary to hemorrhage and platelet dysfunc5on due to chronic kidney disease stage V, this patent required transfusion support of 5 platelet units and two globular packs, who laboratorially reflected an increase in platelet levels and clinical improvement evaluated with the Glasgow Coma Scale
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Seligsohn U, Coller BS. Clasificación, manifestaciones clínicas y evaluación de los trastornos de la hemostasia. En William's hematology, Beutler E, Lichtman MA, Coller BS, Kipps TJ y Seligsohn U. McGraw Hill; Nueva York. 2001; 1471-1478.
II. Kaushansky K, Roth GJ. Megacariocitos y plaquetas. En Wintrobe's clinical hematology, Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F y Glader B. 11th Edi5on, LipincoD Williams & Wilkins; Philadelphia. 2004; 486-526.
III. Briggs C, Harrison P, Machin SJ. Con5nuing developments with the automated platelet count. Int J Lab Hematol 2007; 29: 77-91.
IV. Teo CP, Kueh YK. Incidence of thrombocytopenia in an acute care hospital. Ann Acad Med Singapore 1989; 18: 379-381.
V. Hanes SD, Quarles DA, Boucher BA. Incidence and risk factors of thrombocytopenia in cri5cally ill trauma patients. Ann Pharmacother 1997; 31: 285-289.
VI. F. Sánchez Méndez.Un paciente con plaquetopenia. Elsevier. páginas 340-347 (Noviembre 2001).
VII. Santamaría M, Arias S, Rodríguez M. Hemorragia Subaracnoidea: Malformaciones arteriovenosas. ELSEVIER.2019 [Citado 07 Marzo 2020];12, (70), 4097-4107.
VIII. Valverde M. Hemorragia Subaracnoidea. Rev Med Costa Rica LXXIII.2016 [Citado 07 Marzo 2020];73(619)221-226.Disponible en:
IX. Macdonald RL, Schweizer TA. Hemorragia subaracnoidea espontánea. The Lancet.2017[Citado 07 Marzo 2020];389,655-666.
X. Abraham MK, Chan WT. Hemorragia subaracnoidea. Em Clin OfNorth America ELSEVIER.2016[Citado 07 Marzo 2020];34,(4),901-916.
XI. Ximénez-Carrillo A, Vivancos Mora J. Hemorragia subaracnoidea. Medicina.2015 [Citado 07 Marzo 2020];11, (71),4252-4262.
XII. Ortega Zufiría J et al, Hemorragia subaracnoidea aneurismá5ca: avances clínicos. Neurol. Arg.2016 [Citado 07 Marzo 2020];9(2),96-107.
XIII. Irimia Sieira P, Esparragosa I, Valenz R, Marznez-Vila E. Enfermedades cerebrovasculares. Hemorragia cerebral. Med ELSEVIER. 2019 [ Citado 08 Marzo 2020];12, (70), 4075-4084.
XIV. Yu Wengui, Kavi Tapan, Majic Tamara, Alva Kimberly, Moheet Asma, Lyden Patrick, Schievink Wouter, Lekovic Gregory, Alexander Michael. Treatment Modality and Quality Benchmarks of Aneurysmal Subarachnoid Hemorrhage at a Comprehensive Stroke Center.
XV. Front. Neurol.[Internet] 2018 [Citado 07 Marzo 2020];9,152